Page last updated: 2024-11-03

probenecid and Paranasal Sinus Diseases

probenecid has been researched along with Paranasal Sinus Diseases in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Paranasal Sinus Diseases: Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.

Research Excerpts

ExcerptRelevanceReference
"Actinomycosis is a rare anaerobic bacterial infection typically caused by Actinomyces israelii."2.49Invasive sinonasal actinomycosis: case report and literature review. ( Day, C; Suh, JD; Vorasubin, N; Wu, AW, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vorasubin, N1
Wu, AW1
Day, C1
Suh, JD1

Reviews

1 review available for probenecid and Paranasal Sinus Diseases

ArticleYear
Invasive sinonasal actinomycosis: case report and literature review.
    The Laryngoscope, 2013, Volume: 123, Issue:2

    Topics: Actinomycosis; Adjuvants, Pharmaceutic; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacteria

2013